| Accession Number | 0002010019-26-000015 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 4, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Jun 1, 2026 | Sale | 1,802 | $217.52 | $391,970.86 | 138,841 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Jun 1, 2026 | Sale | 413 | $218.84 | $90,382.78 | 138,428 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Jun 1, 2026 | Sale | 213 | $219.34 | $46,719.42 | 138,215 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | Jun 1, 2026 | Sale | 572 | $220.67 | $126,221.75 | 137,643 | Direct | โ | View Details |